The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients

Free Radical Biology and Medicine

Volumn 35, Issue 8, 2003, Pages 882-888

  Góth, László ^a   Vitai, Márta ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Drug Research Center   (Hungary)

Author keywords

Atherosclerosis; B12; Diabetes; Folate; Free radicals; Homocysteine; Hydrogen peroxide; Hypocatalasemia; Reactive oxygen species

Indexed keywords

BIOLOGICAL MARKER; CATALASE; CYANOCOBALAMIN; FOLIC ACID; HAPTOGLOBIN; HEMOGLOBIN; HOMOCYSTEINE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME;

ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CATALASE DEFICIENCY; CELL DAMAGE; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENZYME BLOOD LEVEL; ERYTHROCYTE; ERYTHROCYTE METABOLISM; FEMALE; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUNGARY; INHERITANCE; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0141749475     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00435-0     Document Type: Article

References (29)

1. 2 removing enzyme in human erythrocytes. Blood. 90:1997;4973-4979.
2. Masuoka N., Wakimoto M., Ubuka T., Nakana T. Spectrophotometric determination of hydrogen peroxide catalase activity and rates of hydrogen peroxide removal by erythrocytes . Clin. Chim. Acta. 254:1966;101-112.
3. Eaton J.W., Ma M. Acatalasemia. Scriver C.R., Beaudett A.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited diseases. 2nd ed:1995;2371-2381 McGraw Hill, New York.
4. Jacob H.S., Ingbar S.H., Jandl J.H., Bell S.C. Oxidative hemolysis and erythrocyte metabolism in hereditary acatalasia. J. Clin. Invest. 44:1965;1187-1199.
5. Góth L., Eaton J.W. Hereditary catalase deficiencies and increased risk of diabetes. Lancet. 356:2000;1820-1821.
6. Góth L. A new type of inherited catalase deficiencies its characterization and comparison to the Japanese and Swiss type of acatalasemia . Blood Cells Mol. Dis. 27:2001;512-517.
7. Matsunaga T., Seger R., Hoger L., Tiefenaur L., Hitzig W.H. Congenital acatalasemia. A study of neutrophil function after provocation with hydrogen peroxide. Pediatr. Res. 19:1985;1187-1190.
8. Góth L., Lenkey A., Bigler N.W. Blood catalase deficiency and diabetes in Hungary. Diabetes Care. 24:2001;1839-1840.
9. Heales S.J.R. Catalase deficiency, diabetes, and mitochondrial function. Lancet. 357:2001;314.
10. Góth L. Lipid and carbohydrate metabolism in acatalasemia. Clin. Chem. 46:2000;564-566.
11. Amensen E., Refsun H., Bona K.H., Ueland P.M., Forde O.H., Nordrehuag J.E. Serum total homocysteine and coronary heart disease. Int. J. Epidemol. 24:1995;704-709.
12. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1997;1775-1781.
13. Xu D., Neville R., Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett. 470:2000;1187-1190.
14. 2 act synergistically to enhance mitochondrial damage . J. Biol. Chem. 273:1998;30808-30817.
15. Huang R.F.S., Huang S.M., Lin B.S., Wei J.S., Liu T.Z. Homocysteine thiolactone induces apoptopic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci. 68:2001;2781-2799.
16. Drunat S., Moatti N., Paul J.L., Benoit M.O., Demuth K. Homocysteine-induced decrease in endothelin-1 production is inhibited at the extracellular level and involves oxidative products. Eur. J. Biochem. 268:2001;5827-5894.
17. Nishio E., Wantanabe Y. Homocysteine as a modulator of platelet-derived growth factor in vascular smooth cells a possible role of hydrogen peroxide . Br. J. Pharmacol. 122:1997;269-274.
18. Widner B., Enzinger C., Laich A., Wirleitner B., Fuchs D. Hyperhomocysteinemia, pteridines and oxidative stress. Curr. Drug Metab. 3:2002;225-232.
19. Ashifield P.A.L., Moat S.J., Newcombe R.G., McDowell I.F.W. Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12. Lancet. 360:2002;171-172.
20. Carmel R., Mallidi P.V., Vinarsky S., Brar S., Frouhar Z. Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States. Am. J. Hematol. 70:2001;107-114.
21. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta. 196:1991;143-151.
22. Vitai M., Góth L. Reference ranges of normal blood catalase activity and levels in familial hypocatalasemia in Hungary. Clin. Chim. Acta. 261:1995;35-42.
23. Wall R., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro a model for the study of vascular injury . Thromb. Res. 18:1980;113-121.
24. Starkebaum G., Harian J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
25. Klein A., Ackerman S.A. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. 111:2003;785-793.
26. Soberman R.J. Series introduction the expanding network of redox signaling: new observations, complexities, and perspectives . J. Clin. Invest. 111:2003;571-574.
27. Nagababu E., Chrest F.J., Rifkind J.M. Hydrogen-peroxide-induced heme degradation in red blood cells the protective role of catalase and glutathione peroxidase . Biochim. Biophys. Acta. 1620:2003;211-217.
28. May J.M., de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 254:1979;2214-2220.
29. Smulders Y., Rakic M., Treskes M., Slaats E.D., Stehouwer C., Silberbusch J. Fasting and post-methionine homocysteine levels in patients with NIDDM. Diabetes. 46:(Suppl. 1):1997;1148.